‘Suicide’ Gene Therapy for Prostate Cancer Shows Promise

‘Suicide’ Gene Therapy for Prostate Cancer Shows Promise
A phase II trial evaluating combination of radiotherapy and an experimental treatment driving tumor cells to self-destruct achieved promising results in cancer regression and presented no indication of tumor recurrence. The results, entitled “Long-term outcome of a phase II trial using immunomodulatory in situ gene therapy in combination with intensity-modulated radiotherapy with or without hormonal therapy

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *